Eysuvis Approval Status
FDA Approved: No
Brand name: Eysuvis
Generic name: loteprednol etabonate
Company: Kala Pharmaceuticals, Inc.
Treatment for: Dry Eye Disease
Eysuvis (loteprednol etabonate) is an ophthalmic corticosteroid formulation in development for the temporary relief of signs and symptoms of dry eye disease.
Development Status and FDA Approval Process for Eysuvis
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.